Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal

Completed · Phase 1

Conditions studied: Healthy

In brief

The purpose of this study is to evaluate the efficacy of tattoo removal using topical imiquimod, 5% cream in conjunction with the 1064nm Nd:YAG laser. This procedure for tattoo removal will be compared to a laser removal alone.

Key facts

Study ID

NCT00638651

Run by

University of Miami

People needed

3

Starts

2008-02-01

Expected to finish

2014-08-01

Last updated by the study team

2018-03-22

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 2 tattoos no larger than 25cm2, professionally made, with approximately the same age, containing blue/black ink.

You may not qualify if…

• Hypersensitivity to imiquimod
• Current sun tan
• Use of vitamin E, non-steroid anti-inflammatory drugs, coumadin or aspirin for the past 10 days
• Amateur tattoos
• Pregnancy
• Breast-feeding status
• Immunosuppression
• Auto-immune diseases.

Where it is running

• Mohs, Dermatologic and Laser Surgery — Miami, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.